Corline Biomedical AB
STO:CLBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Corline Biomedical AB
Accounts Payable
Corline Biomedical AB
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Corline Biomedical AB
STO:CLBIO
|
Accounts Payable
kr927k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
2%
|
|
|
Orexo AB
STO:ORX
|
Accounts Payable
kr92.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Camurus AB
STO:CAMX
|
Accounts Payable
kr105.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
38%
|
CAGR 10-Years
13%
|
|
|
S
|
Swedencare AB (publ)
STO:SECARE
|
Accounts Payable
kr108.1m
|
CAGR 3-Years
17%
|
CAGR 5-Years
42%
|
CAGR 10-Years
49%
|
|
|
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
Accounts Payable
kr43.9m
|
CAGR 3-Years
71%
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
Accounts Payable
kr400k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Corline Biomedical AB
Glance View
Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2015-06-03. The company develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
See Also
What is Corline Biomedical AB's Accounts Payable?
Accounts Payable
927k
SEK
Based on the financial report for Dec 31, 2025, Corline Biomedical AB's Accounts Payable amounts to 927k SEK.
What is Corline Biomedical AB's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
2%
Over the last year, the Accounts Payable growth was -70%. The average annual Accounts Payable growth rates for Corline Biomedical AB have been -40% over the past three years , -8% over the past five years , and 2% over the past ten years .
